The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study.

The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study.

Item
http://www.wikidata.org/entity/Q47602198
Considering renal risk while managing cancer.Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial.Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma.Determination of intrarenal resistance index (RI) in patients with multiple myeloma.Melphalan and its role in the management of patients with multiple myeloma.State-of-the-Art Management of Complications of Myeloma and Its Treatment.Renal failure in multiple myeloma: a medical emergency.Guidelines for the diagnosis and management of multiple myeloma 2011.Renal allografts in plasma cell myeloma hematopoietic cell graft recipients: on the verge of an explosion?Melphalan 200 mg/m2 in patients with renal impairment is associated with increased short-term toxicity but improved response and longer treatment-free survival.Late recovery of renal failure after autologous haematopoietic stem cell transplantation for multiple myeloma: a report of two cases.Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure.Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting.Encephalopathy: an unusual neurologic complication of autologous hematopoietic stem cell transplant in patients with multiple myeloma with renal failure.Transplantation without growth factor: engraftment kinetics after stem cell transplantation for primary systemic amyloidosis (AL).
P2860

The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study.

Item
http://www.wikidata.org/entity/Q47602198
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The clinical outcome and toxic ...... Marrow Transplantation study.
@en
The clinical outcome and toxic ...... Marrow Transplantation study.
@nl
type
label
The clinical outcome and toxic ...... Marrow Transplantation study.
@en
The clinical outcome and toxic ...... Marrow Transplantation study.
@nl
prefLabel
The clinical outcome and toxic ...... Marrow Transplantation study.
@en
The clinical outcome and toxic ...... Marrow Transplantation study.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
The clinical outcome and toxic ...... Marrow Transplantation study.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2141.2006.06191.X
P407
P433
P478
P577
P5875
P698
P921